Article by Ben Kaplan, Canada.com
After a somewhat harrowing, all-hands-on-deck Tuesday night with the family, I ate a chocolate chip cookie infused with 10 mg of THC at 8:50 p.m. Its effects came on slowly as I sat in the basement and watched a Tom Cruise film, but at roughly 9:30 p.m., I felt relief.
Michelle Rabin, who made the cookie — edibles won’t be on the regulated market until January, but you can make them at home — started baking with cannabis when she began boxing. She describes the feeling perfectly, “like being an elementary school kid coming home with a heavy backpack, walking through the door and dropping the bag on the floor.”
That’s how I felt: my backpack had disappeared, replaced by a goofy empathy and a desire to engage again.
“[I wanted] to make a cookie where someone could eat the whole thing and not get uncomfortably high, just a pleasant high,” says Rabin, who is active and shares her cookies with her canna-curious athlete friends. “I became a person who makes edibles because I was concerned about my cardiovascular health. I loved getting high and working out because it takes some of the stress off your body. I enjoy the lightness of the high.”
Edibles, drinkables and vapes are the hyped 2.0 products that will offer consumers more choices when it comes to cannabis consumption. Even though regulated products aren’t available yet, athletes have been experimenting with cannabis products for some time. Some distance athletes are working to normalize edibles, and Aurora, one of Canada’s largest cannabis companies, has inked a deal with the UFC.
In November, Canopy Growth unveiled 30 new products ready to hit the shelves, including 11 different drinks.
“50 percent of Canadians have never consumed cannabis and we have the opportunity to offer them a benign alternative to alcohol,” says Paul Weaver, director of innovation for the company. He says Canopy’s deal with BioSteel Sports Nutrition — makers of the Gatorade-like concoction used by the NFL, NBA and Major League Baseball — brings a team of scientists to report on evidence-based research that will go beyond the anecdotal to support CBD’s medicinal claims.
“The number one reason people reject cannabis is they don’t like to smoke; number two is that it was illegal, so we think the 2.0 products open a lot of doors to a whole new group of consumers, including people who play sports,” he says.
Consuming 2.0 products isn’t radically different from smoking flower, but it isn’t the same, either. Canopy’s research and development team is working on reducing the length of time it takes to feel the onset of the buzz, aiming to make it similar to the quick onset of an alcohol buzz.